Annual ROA
-91.72%
+77.65%+45.85%
31 December 2023
Summary:
Titan Pharmaceuticals annual return on assets is currently -91.72%, with the most recent change of +77.65% (+45.85%) on 31 December 2023. During the last 3 years, it has risen by +17.43% (+15.97%). TTNP annual ROA is now -304.23% below its all-time high of 44.91%, reached on 31 December 2013.TTNP ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-75.11%
+2.47%+3.18%
30 June 2024
Summary:
Titan Pharmaceuticals quarterly return on assets is currently -75.11%, with the most recent change of +2.47% (+3.18%) on 30 June 2024. Over the past year, it has increased by +30.64% (+28.97%). TTNP quarterly ROA is now -202.65% below its all-time high of 73.17%, reached on 31 March 1998.TTNP Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTNP ROA Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | +29.0% |
3 y3 years | +16.0% | +12.6% |
5 y5 years | +34.2% | +57.0% |
TTNP ROA High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +55.7% | at high | +61.6% |
5 y | 5 years | -16.9% | +55.7% | at high | +63.9% |
alltime | all time | -304.2% | +63.2% | -202.7% | +74.5% |
Titan Pharmaceuticals ROA History
Date | Annual | Quarterly |
---|---|---|
June 2024 | - | -75.11%(-3.2%) |
Mar 2024 | - | -77.58%(-26.6%) |
Dec 2023 | -91.72%(-45.8%) | -105.75%(-26.9%) |
Sept 2023 | - | -144.74%(-26.0%) |
June 2023 | - | -195.65%(+30.4%) |
Mar 2023 | - | -149.99%(+8.6%) |
Dec 2022 | -169.37%(+55.2%) | -138.05%(+15.4%) |
Sept 2022 | - | -119.64%(+20.9%) |
June 2022 | - | -98.97%(+21.6%) |
Mar 2022 | - | -81.41%(-5.3%) |
Dec 2021 | -109.15%(-47.3%) | -85.96%(-5.8%) |
Sept 2021 | - | -91.25%(-24.3%) |
June 2021 | - | -120.49%(-16.6%) |
Mar 2021 | - | -144.46%(-22.9%) |
Dec 2020 | -207.19%(+48.7%) | -187.48%(-9.9%) |
Sept 2020 | - | -208.18%(+9.5%) |
June 2020 | - | -190.19%(+0.5%) |
Mar 2020 | - | -189.30%(+8.4%) |
Dec 2019 | -139.37%(+77.6%) | -174.63%(+7.8%) |
Sept 2019 | - | -161.98%(+3.5%) |
June 2019 | - | -156.49%(+35.4%) |
Mar 2019 | - | -115.60%(+14.7%) |
Dec 2018 | -78.46%(-24.4%) | -100.79%(-4.7%) |
Sept 2018 | - | -105.73%(-23.5%) |
June 2018 | - | -138.22%(-1.8%) |
Mar 2018 | - | -140.69%(+23.5%) |
Dec 2017 | -103.78%(-422.9%) | -113.91%(+36.0%) |
Sept 2017 | - | -83.78%(+32.2%) |
June 2017 | - | -63.36%(-395.0%) |
Mar 2017 | - | 21.48%(-22.4%) |
Dec 2016 | 32.14%(-148.6%) | 27.67%(-4.7%) |
Sept 2016 | - | 29.03%(-19.6%) |
June 2016 | - | 36.12%(-166.6%) |
Mar 2016 | - | -54.21%(-18.5%) |
Dec 2015 | -66.08%(+439.9%) | -66.54%(+19.1%) |
Sept 2015 | - | -55.85%(+35.3%) |
June 2015 | - | -41.27%(+24.4%) |
Mar 2015 | - | -33.18%(+128.8%) |
Dec 2014 | -12.24%(-127.3%) | -14.50%(+5.1%) |
Sept 2014 | - | -13.79%(-44.0%) |
June 2014 | - | -24.62%(-333.8%) |
Mar 2014 | - | 10.53%(-78.5%) |
Dec 2013 | 44.91%(-151.8%) | 48.94%(-7.1%) |
Sept 2013 | - | 52.67%(+226.9%) |
June 2013 | - | 16.11%(-161.5%) |
Mar 2013 | - | -26.19%(-78.1%) |
Dec 2012 | -86.63%(-57.4%) | -119.80%(-39.3%) |
Sept 2012 | - | -197.43%(+61.0%) |
June 2012 | - | -122.64%(-43.8%) |
Mar 2012 | - | -218.16%(-3.6%) |
Dec 2011 | -203.13%(+26.0%) | -226.38%(-13.0%) |
Sept 2011 | - | -260.18%(-11.8%) |
June 2011 | - | -294.86%(+39.2%) |
Mar 2011 | - | -211.90%(+64.7%) |
Dec 2010 | -161.22% | -128.65%(+75.2%) |
Sept 2010 | - | -73.42%(-37.7%) |
Date | Annual | Quarterly |
---|---|---|
June 2010 | - | -117.90%(+29.2%) |
Mar 2010 | - | -91.28%(-42.2%) |
Dec 2009 | -34.05%(-55.7%) | -157.97%(+88.4%) |
June 2009 | - | -83.85%(-8.0%) |
Mar 2009 | - | -91.11%(-25.8%) |
Sept 2008 | - | -122.78%(+11.9%) |
June 2008 | - | -109.73%(+12.4%) |
Mar 2008 | - | -97.59%(+0.4%) |
Dec 2007 | -76.92%(-15.0%) | -97.24%(+4.1%) |
Sept 2007 | - | -93.44%(+9.2%) |
June 2007 | - | -85.59%(+8.3%) |
Mar 2007 | - | -79.01%(+0.8%) |
Dec 2006 | -90.50%(+17.6%) | -78.39%(+1.1%) |
Sept 2006 | - | -77.52%(-4.5%) |
June 2006 | - | -81.18%(-2.2%) |
Mar 2006 | - | -83.00%(+2.9%) |
Dec 2005 | -76.97%(+29.7%) | -80.68%(+1.6%) |
Sept 2005 | - | -79.41%(+18.5%) |
June 2005 | - | -67.01%(+17.1%) |
Mar 2005 | - | -57.24%(+6.7%) |
Dec 2004 | -59.35%(+24.0%) | -53.66%(-2.8%) |
Sept 2004 | - | -55.23%(+7.0%) |
June 2004 | - | -51.63%(+2.6%) |
Mar 2004 | - | -50.32%(+5.5%) |
Dec 2003 | -47.85%(+55.4%) | -47.70%(+17.5%) |
Sept 2003 | - | -40.60%(+6.0%) |
June 2003 | - | -38.30%(+8.1%) |
Mar 2003 | - | -35.43%(+15.1%) |
Dec 2002 | -30.79%(+98.9%) | -30.77%(+18.4%) |
Sept 2002 | - | -25.99%(+17.7%) |
June 2002 | - | -22.08%(+35.0%) |
Mar 2002 | - | -16.36%(+6.1%) |
Dec 2001 | -15.48%(-31.7%) | -15.42%(+9.9%) |
Sept 2001 | - | -14.03%(-24.5%) |
June 2001 | - | -18.59%(-8.4%) |
Mar 2001 | - | -20.30%(-10.1%) |
Dec 2000 | -22.66%(-40.2%) | -22.59%(-21.5%) |
Sept 2000 | - | -28.79%(+20.9%) |
June 2000 | - | -23.81%(-32.5%) |
Mar 2000 | - | -35.29%(-38.8%) |
Dec 1999 | -37.92%(-32.4%) | -57.67%(-35.1%) |
Sept 1999 | - | -88.87%(+8.6%) |
June 1999 | - | -81.84%(+19.5%) |
Mar 1999 | - | -68.49%(+17.0%) |
Dec 1998 | -56.08%(-2060.8%) | -58.56%(-268.3%) |
Sept 1998 | - | 34.80%(+18.3%) |
June 1998 | - | 29.41%(-59.8%) |
Mar 1998 | - | 73.17%(+1711.1%) |
Dec 1997 | 2.86%(-102.3%) | 4.04%(-103.3%) |
Sept 1997 | - | -122.81%(+7.7%) |
June 1997 | - | -114.00%(-32.4%) |
Mar 1997 | - | -168.65%(+60.5%) |
Dec 1996 | -122.27%(-50.9%) | -105.05%(-0.7%) |
Sept 1996 | - | -105.78%(-25.7%) |
June 1996 | - | -142.29%(-3.8%) |
Mar 1996 | - | -147.88%(-40.6%) |
Dec 1995 | -248.94% | -248.94% |
FAQ
- What is Titan Pharmaceuticals annual return on assets?
- What is the all time high annual ROA for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals quarterly return on assets?
- What is the all time high quarterly ROA for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals quarterly ROA year-on-year change?
What is Titan Pharmaceuticals annual return on assets?
The current annual ROA of TTNP is -91.72%
What is the all time high annual ROA for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high annual return on assets is 44.91%
What is Titan Pharmaceuticals quarterly return on assets?
The current quarterly ROA of TTNP is -75.11%
What is the all time high quarterly ROA for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high quarterly return on assets is 73.17%
What is Titan Pharmaceuticals quarterly ROA year-on-year change?
Over the past year, TTNP quarterly return on assets has changed by +30.64% (+28.97%)